Vimta Labs Ltd
Vimta Labs | 524394
Share Price Chart - Vimta Labs Ltd
Stock Performance
Ratios
About Company
- , established in 1984, is India's most comprehensive contract research and testing organization, providing wide range of services to pharmaceutical, biopharmaceutical, food, consumer goods, electronic, electrical, agrochemical, healthcare, medical device and many other industries
- Broadly, these services include: Drug discovery, development and drug life cycle management support services in the areas like preclinical research (GLP and non-GLP), clinical research, central lab, and cGMP as well as non-GMP analytical services for pharmaceutical and biopharmaceutical companies; Preclinical research and testing services for medical device companies; Contract research and testing for Agro-science companies; Food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, regulators; Clinical diagnostics services to patients, clinicians, hospitals and Environmental regulatory services such as impact assessments and post project monitoring, to industries such as infrastructure, power, cement, oil & gas, mining etc; EMI/EMC testing for electronic and electrical products
- In 1997, the Company entered into a Joint Venture with Russian Centre for Testing and Certification, ROSTEST Moscow with an investment of 24% of the total Paidup Captial
- The main essence of this Joint Venture was to diversify the activities in to preshipment inspection services for all Indian exports to Russia
- During 2002, the company began to offer Clinical Diagnostics Services
- Clinical Specialty Diagnostics has been an internal requirement to screen the clinical trial subjects
- Facilities were created in the year 2000 to speed up the clinical trials
- During the year 2006-07, the Analytical and Clinical Reference Lab facilities was shifted from the existing Cherlapally Facility to the newly established Life Sciences Facility in S
- Biotech Park, Genome Valley, Hyderabad which started commercial operations from September, 2006
- During the year 2020 Company acquired 100% Equity Shares of Emtac Laboratories Private Limited, on 04th March 2020, making Emtac a wholly owned subsidiary of the Company
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Vimta Labs Ltd?
The current share price of Vimta Labs Ltd (Vimta Labs) is ₹566.10. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Vimta Labs Ltd?
The Price-to-Earnings (P/E) ratio of Vimta Labs Ltd is 566.10. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Vimta Labs Ltd?
Vimta Labs Ltd has a 52-week high of ₹902.65 and a 52-week low of ₹376.05. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Vimta Labs Ltd?
Vimta Labs Ltd offers a dividend yield of 0.21%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Vimta Labs Ltd?
The Earnings Per Share (EPS) of Vimta Labs Ltd is ₹13.61. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Vimta Labs Ltd?
Vimta Labs Ltd has a Return on Equity (ROE) of 18.55%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
